** = Publikationen gelistet in SCI/SSCI/Pubmed
** Haas, D; Pikal, SR; Galler, H; Habib, J; Moser, T; Ofner-Kopeinig, P; Schalli, M
Particulate matter and airborne microorganisms in a construction site in Graz, Austria
ATMOS ENVIRON. 2025; 344: 121025
Doi: 10.1016/j.atmosenv.2024.121025
Web of Science
FullText
FullText_MUG
** Guigal-Stephan, N; Lockhart, B; Moser, T; Heitzer, E
A perspective review on the systematic implementation of ctDNA in phase I clinical trial drug development.
J Exp Clin Cancer Res. 2025; 44(1):79
Doi: 10.1186/s13046-025-03328-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bonstingl, L; Skofler, C; Ulz, C; Zinnegger, M; Sallinger, K; Schönberger, J; Schuch, K; Pankratz, K; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies-Information Everybody Wants but Nobody Wants to Pay For.
Clin Chem. 2024; 70(9): 1140-1150.
Doi: 10.1093/clinchem/hvae079
Web of Science
PubMed
FullText
FullText_MUG
** Moser, T; Heitzer, E
Surpassing sensitivity limits in liquid biopsy.
Science. 2024; 383(6680): 260-261.
Doi: 10.1126/science.adn1886
Web of Science
PubMed
FullText
FullText_MUG
** Moser, T; Kühberger, S; Lazzeri, I; Vlachos, G; Heitzer, E
Bridging biological cfDNA features and machine learning approaches.
Trends Genet. 2023; 39(4): 285-307.
Doi: 10.1016/j.tig.2023.01.004
Web of Science
PubMed
FullText
FullText_MUG
** Seidel, MG; Kashofer, K; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Leithner, A; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E
Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents.
Front Pediatr. 2022; 10: 926405
Doi: 10.3389/fped.2022.926405
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buder, A; Heitzer, E; Waldispühl-Geigl, J; Weber, S; Moser, T; Hochmair, MJ; Hackner, K; Errhalt, P; Setinek, U; Filipits, M
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients.
BIOMOLECULES. 2021; 11(5):
Doi: 10.3390/biom11050618
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J
Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125
Doi: 10.1177/17588359211029125
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Unseld, M; Belic, J; Pierer, K; Zhou, Q; Moser, T; Bauer, R; Piringer, G; Gerger, A; Siebenhüner, A; Speicher, M; Heitzer, E; Prager, GW
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Int J Cancer. 2021; 148(6):1452-1461
Doi: 10.1002/ijc.33303
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML; Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Heitzer, E; Groen, HJM
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
JCO PRECIS ONCOL. 2021; 5: 1540-1553.
Doi: 10.1200/PO.21.00182
Web of Science
PubMed
FullText
FullText_MUG
** Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A
A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer.
Cancers (Basel). 2020; 12(8):
Doi: 10.3390/cancers12082247
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, SO; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Heitzer, E; Geigl, JB; Bauernhofer, T; Speicher, MR
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
NPJ Precis Oncol. 2020; 4(1):30
Doi: 10.1038/s41698-020-00134-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smith, CG; Moser, T; Mouliere, F; Field-Rayner, J; Eldridge, M; Riediger, AL; Chandrananda, D; Heider, K; Wan, JCM; Warren, AY; Morris, J; Hudecova, I; Cooper, WN; Mitchell, TJ; Gale, D; Ruiz-Valdepenas, A; Klatte, T; Ursprung, S; Sala, E; Riddick, ACP; Aho, TF; Armitage, JN; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Welsh, SJ; Matakidou, A; Eisen, T; Massie, CE; Rosenfeld, N; Heitzer, E; Stewart, GD
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Genome Med. 2020; 12(1): 23-23.
Doi: 10.1186/s13073-020-00723-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2020; 11(1): 1965-1965.
Doi: 10.1038/s41467-020-15799-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666.
Doi: 10.1038/s41467-019-12714-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, T; Smith, CG; Seles, M; Wcislo, G; Eldridge, M; Perakis, S; Mouliere, F; Lazzeri, I; Heider, K; Warren, A; Rosenfeld, N; Stewart, GD; Heitzer, E
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
CANCER RES. 2019; 79(13):-AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology; MAR 29-APR 03, 2019; Atlanta, GA.
Doi: 10.1158/1538-7445.AM2019-1367
[Poster]
Web of Science
FullText
FullText_MUG
** Zhou, Q; Moser, T; Perakis, S; Heitzer, E
Untargeted profiling of cell-free circulating DNA
TRANSL CANCER RES. 2018; 7: S140-S152.
Doi: 10.21037/tcr.2017.10.11
Web of Science
FullText
FullText_MUG
** Moser, T; Ulz, P; Zhou, Q; Perakis, S; Geigl, JB; Speicher, MR; Heitzer, E
Single-Stranded DNA Library Preparation Does Not Preferentially Enrich Circulating Tumor DNA.
Clin Chem. 2017; 63(10):1656-1659
Doi: 10.1373/clinchem.2017.277988
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, T; Fertl, E; Koppi, S; Seifert-Held, T; Safoschnik, G; Bsteh, G; Heller, T; Rommer, P; Baumgartner, A; Berger, T; Sellner, J
Natalizumab-related progressive multifocal leukoencephalopathy in Austria: An observational nationwide study
EUR J NEUROL. 2017; 24: 38-38.-3rd Congress of the European-Academy-of-Neurology; JUN, 2017; Amsterdam, NETHERLANDS.
[Poster]
Web of Science